CAREPLUS GROUP |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.285 MYR | +3.64% |
|
+3.64% | -32.94% |
| Feb. 21 | Careplus Group Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
| Jan. 19 | Careplus Closes MYR2.7 Million Purchase of GVT | MT |
| Sales 2021 | 700M 146M | Sales 2022 * | - | Capitalization | 159M 33.24M |
|---|---|---|---|---|---|
| Net income 2021 | 221M 46.21M | Net income 2022 * | - | EV / Sales 2021 | 1.15 x |
| Net cash position 2021 | 106M 22.1M | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
| P/E ratio 2021 |
4.19
x | P/E ratio 2022 * |
-
| Employees | 2,246 |
| Yield 2021 |
2.42% | Yield 2022 * |
-
| Free-Float | 75.72% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.64% | ||
| 1 week | +3.64% | ||
| Current month | +3.64% | ||
| 1 month | -1.72% | ||
| 3 months | -22.97% | ||
| 6 months | +9.62% | ||
| Current year | -32.94% |
1 week
0.27
0.29
1 month
0.270.30
Current year
0.270.45
1 year
0.250.51
3 years
0.223.09
5 years
0.135.83
10 years
0.135.83
| Managers | Title | Age | Since |
|---|---|---|---|
Kwee Shyan Lim
CEO | Chief Executive Officer | 60 | - |
Chee Keong Lim
DFI | Director of Finance/CFO | 54 | 11-08-31 |
Khoo Boon Keong
ADM | Chief Administrative Officer | 50 | 11-10-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Leng Chooi Ooi
BRD | Director/Board Member | 58 | 18-05-31 |
Kuan Ming Foong
BRD | Director/Board Member | 69 | 10-09-13 |
Kwee Shyan Lim
CEO | Chief Executive Officer | 60 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +0.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 0.285 | +3.64% | 2,536,800 |
| 24-04-23 | 0.275 | +1.85% | 6,139,300 |
| 24-04-22 | 0.27 | 0.00% | 1,215,200 |
| 24-04-19 | 0.27 | -1.82% | 4,261,000 |
| 24-04-18 | 0.275 | 0.00% | 2,690,900 |
End-of-day quote BURSA MALAYSIA, April 23, 2024
More quotes
Careplus Group Berhad is a Malaysia-based investment holding company. The Company is engaged in the manufacturing and sales of latex and nitrile gloves. The Company's products include Latex Exam Gloves, Nitrile Exam Gloves and Surgical Gloves. Latex Exam Gloves are suitable for use in medical examinations and procedures, diagnostic procedures by dentist, laboratory practices and food handling practices. The Company provides examination-grade nitrile gloves, which protect from common chemicals. It also provides surgical powdered and powder free sterile latex gloves. Its subsidiaries include Rubbercare Protection Products Sdn. Bhd., which is engaged in the manufacturing of rubber gloves; Careglove Global Sdn. Bhd., which is a manufacturer, commission agent, representative, processor, distributor, importer and exporter of all types of hand gloves, and Careplus Properties Sdn. Bhd., which is engaged in investment holding, provision of gloves packing and warehousing services.
Calendar
2024-05-23
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -32.94% | 41.77M | |
| -33.90% | 2.9B | |
| -9.29% | 2.71B | |
| +2.61% | 2.14B | |
| -0.74% | 1.91B | |
| -13.01% | 1.84B | |
| -5.56% | 1.42B | |
| -2.49% | 1.26B | |
| +14.05% | 1.13B | |
| +3.15% | 1.13B |
- Stock Market
- Equities
- CAREPLS Stock
